![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serious adverse events and coping strategies of CAR-T cells in the treatment of malignant tumors
Xiujin Chen, Peng Li, Bin Tian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Xiujin Chen, Peng Li, Bin Tian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Showing 8 citing articles:
Challenges and overcoming strategies in CAR-T cell therapy for pediatric neuroblastoma
Pei-Ting Ying, Yongmin Tang
World Journal of Pediatrics (2025)
Closed Access
Pei-Ting Ying, Yongmin Tang
World Journal of Pediatrics (2025)
Closed Access
The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?
Zhaokai Zhou, Ge Zhang, Yudi Xu, et al.
Cancer Letters (2024) Vol. 597, pp. 217083-217083
Closed Access | Times Cited: 5
Zhaokai Zhou, Ge Zhang, Yudi Xu, et al.
Cancer Letters (2024) Vol. 597, pp. 217083-217083
Closed Access | Times Cited: 5
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Meng–Yao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Meng–Yao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Leukapheresis for CAR-T cell production and therapy
Ilias Pessach, Arnon Nagler
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 6, pp. 103828-103828
Closed Access | Times Cited: 7
Ilias Pessach, Arnon Nagler
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 6, pp. 103828-103828
Closed Access | Times Cited: 7
Quality of Life Evaluation in Patients with Follicular Cell Lymphoma: A Real-World Study in Europe and the United States
P. Connor Johnson, Abigail Bailey, Q.Y. Ma, et al.
Advances in Therapy (2024) Vol. 41, Iss. 8, pp. 3342-3361
Open Access | Times Cited: 1
P. Connor Johnson, Abigail Bailey, Q.Y. Ma, et al.
Advances in Therapy (2024) Vol. 41, Iss. 8, pp. 3342-3361
Open Access | Times Cited: 1
Application of CAR-T cell therapy targeting mesothelin in solid tumor treatment
Qiuhong Chen, Yang Sun, Hua Li
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Qiuhong Chen, Yang Sun, Hua Li
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies
Yangjie Liu, Peng Cao, Faiza Ahad, et al.
Recent Patents on Anti-Cancer Drug Discovery (2024) Vol. 19, Iss. 5, pp. 557-572
Closed Access
Yangjie Liu, Peng Cao, Faiza Ahad, et al.
Recent Patents on Anti-Cancer Drug Discovery (2024) Vol. 19, Iss. 5, pp. 557-572
Closed Access
CAR-T therapy pulmonary adverse event profile: a pharmacovigilance study based on FAERS database (2017–2023)
Jing Shi, Xinya Liu, Yun Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Jing Shi, Xinya Liu, Yun Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes
Amy E. Armstrong, Yuting Tang, Neelam Mukherjee, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Amy E. Armstrong, Yuting Tang, Neelam Mukherjee, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access